UNITED KINGDOM, March 3, 2025 /EINPresswire.com/ -- Renowned private ENT surgeon Adam Shakir offers new ways of dealing with children's recurrent tonsillitis and ...
A new editorial paper was published in Oncoscience (Volume 10) on June 28, 2023, entitled, "Adenoid cystic carcinoma of the head and neck – treatment strategies of a highly malignant tumor with ...
SALT LAKE CITY, Feb. 8, 2021 /PRNewswire/ — Elevar Therapeutics, Inc. ("Elevar"), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for ...
Pilot study evaluating the addition of cemiplimab in BRAF-mutant anaplastic thyroid cancer after progression on dabrafenib and trametinib. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
- REM-422 granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of ACC and AML - Advances REM-422, an oral small molecule messenger RNA (mRNA) degrader to ...
RUDN doctors have discovered genetic and viral causes of a frequent ENT disease in children - adenoid hypertrophy. The results are published in Life. Adenoid hypertrophy (AH), or their overgrowth, is ...
Down-regulation of target gene expression in human white blood cells (hWBCs) by MRX34, a liposomal miR-34 mimic: Next generation sequencing (NGS) results from a first-in-human trial of microRNA cancer ...
“Proton therapy [...] seems to have decisive advantages with regard to the long-term survival of [adenoid cystic carcinoma] [...]” In general, tumors originating from the minor salivary glands often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback